Dudediligence.

Phio Pharmaceuticals Corp

PHIONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$1.5MSep ’24−$1.6MDec ’24−$1.8MMar ’25−$2.2MJun ’25−$2.4MSep ’25−$2.4MDec ’25−$4.0MMar ’26−$4.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$13.5M−$11.5M−$10.8M−$7.4M−$9.2M
Net income−$13.3M−$11.5M−$10.8M−$7.2M−$8.7M
Operating cash flow−$11.9M−$12.1M−$10.7M−$7.1M−$8.0M
Free cash flow−$11.9M−$12.3M−$10.8M−$7.1M−$8.0M
Cash$24.1M$11.8M$8.5M$5.4M$21.0M
Debt$0.00none on filenone on filenone on filenone on file
Shares outstanding1.1M1.1M416.4K1.7M11.6M